Capital expenditure decreased 87.1%
Capital expenditure changed -87.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -87.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +92.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +60.9% from the comparable as-filed period.
Inventory changed +54.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed +104.8% from the comparable as-filed period.
Selling, general & administrative changed +42.2% from the comparable as-filed period.
Trade receivables changed +38.6% from the comparable as-filed period.
Working capital / assets changed -220 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current ratio changed -15.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.